News

A major scientific advance in protein modeling developed by Microsoft Research AI for Science, has been published in Science.
After years of development, Isomorphic Labs says its AI-created drugs are nearly ready for human trials. Isomorphic Labs, the ...
AI is reshaping life sciences. Learn how compliant, explainable, and genuinely useful systems move from pilot to scale and ...
Bristol-Myers Squibb Company (NYSE:BMY) is one of the 10 Best Cheap Stocks to Buy According to Billionaire Ray Dalio.
Why a fundamental reimagining of how clinical studies operate is still necessary to achieve a true paradigm shift—and shed ...
The way we study new medicines and treatments is changing quickly. One of the biggest reasons for this change is the use of ...
Artificial intelligence (AI) should soon be taking a greater role in areas including patient recruitment and in building efficiencies around data quality.
PhaseV, a leader in AI/ML for clinical development, today announced the launch of its Trial Optimizer platform, a key component of its holistic solution, on Amazon Web Services (AWS) Marketplace. This ...
Kuick Research Report highlights ongoing Clinical Development Technology platforms In Recent Research Study On KIF18A ...
Artificial intelligence (AI) transforms oncology by enhancing clinical decision-making, improving patient outcomes, and ...
AI is changing how drugs are manufactured, particularly when it comes to getting them approved. Because it is so fast at processing information, the whole appro ...